Zymeron
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Park Offices Dr Ste 211, Durham, Nor...Phone Number
(919) 748-3319Website
www.zymeron.comRevenue
<$5 MillionIndustry
About Zymeron
Zymeron is a preclinical pharmaceutical startup focused on developing myeloprotective, cardioprotective, and neuroprotective drugs aimed at enhancing the health of hematopoietic, cardiovascular, and cerebrovascular systems. Their MyeloShield Therapeutics is designed to transform the management of myelosuppression and cytopenia for chemotherapy patients, shifting from reactive to preventive care. The company also specializes in innovative drug delivery systems, including a proprietary peptide drug conjugate that protects stem cells from chemotherapy-induced damage. Zymeron collaborates with various partners across academia, industry, and government to address unmet clinical needs and advance health-related technologies.Explore more
Zymeron Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Zymeron
Compare insights from companies similar to Zymeron, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zymeron Tech Stack
A closer look at the technologies used by Zymeron
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zymeron
Sign Up For FreeTo access detailed company insights
Zymeron is a preclinical pharmaceutical startup focused on developing myeloprotective, cardioprotective, and neuroprotective drugs aimed at enhancing the health of hematopoietic, cardiovascular, and cerebrovascular systems. Their MyeloShield Therapeutics is designed to transform the management of myelosuppression and cytopenia for chemotherapy pati... Read More
